Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502) (NCT04687020)

🧪 Interventions in This Study

• Viltolarsen (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (5 Sites)

• UC Davis — Sacramento, California
• Lurie Children's Hospital — Chicago, Illinois
• Duke University Medical Center — Durham, North Carolina
• Children's Hospital of Richmond at VCU — Richmond, Virginia
• Alberta Children's Hospital — Calgary, Alberta

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Duchenne Muscular Dystrophy

• Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy — Little Rock, Arkansas
• Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD — Columbus, Ohio
• Microdystrophin Gene Transfer Study in Adolescents and Children With DMD — Los Angeles, California
• NS-050/NCNP-03 in Boys With DMD (Meteor50) — Los Angeles, California
• A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD) — Little Rock, Arkansas
• Pediatric Radio Frequency Coils Generic — Cincinnati, Ohio

Explore by condition: All Duchenne Muscular Dystrophy clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.